Ghost Tree Capital’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Ghost Tree Capital’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-40,000	Closed	-$2.18M	–	67
2019 Q4	$2.18M	Sell	40,000 -310,000	-89%	-$15.4M	0.41%	44
2019 Q3	$14.6M	Buy	350,000 +250,000	+250%	+$10.6M	3.72%	9
2019 Q2	$4.38M	Buy	+100,000	New	+$5.64M	0.91%	30
2019 Q1	–	Sell	-275,000	Closed	-$11.9M	–	53
2018 Q4	$10.2M	Buy	275,000 +75,000	+38%	+$2.7M	3.69%	8
2018 Q3	$7.51M	Buy	+200,000	New	+$7.36M	1.6%	25
2018 Q2	–	Sell	-550,000	Closed	-$17.5M	–	71
2018 Q1	$14.2M	Buy	550,000 +365,000	+197%	+$10.9M	2.87%	10
2017 Q4	$4.99M	Buy	+185,000	New	+$5.09M	1.17%	30

Other funds holding BHVN

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Ghost Tree Capital's BHVN Position: Q1 2020 in Review

Ghost Tree Capital sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q1 2020, closing a stake of 40,000 shares — an estimated $2.18M sold.

Ghost Tree Capital first reported a position in BHVN in Q4 2017 and held it in 7 quarters. The position peaked at $14.6M in Q3 2019. 175 funds tracked by Wall St. Rank hold BHVN as of Q1 2020.

Ghost Tree Capital reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q1 2020 after selling out during the quarter.
Ghost Tree Capital sold 40,000 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2020, an estimated $2.18M.
Ghost Tree Capital first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2017 and held it in 7 quarters.
Ghost Tree Capital's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $14.6M in Q3 2019.
175 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2020.

Based on Ghost Tree Capital's 13F filing for Q1 2020, filed 15 May 2020.